MA27313A1 - Pates veterinaires homogenes orales anthelminthiques. - Google Patents
Pates veterinaires homogenes orales anthelminthiques.Info
- Publication number
- MA27313A1 MA27313A1 MA28026A MA28026A MA27313A1 MA 27313 A1 MA27313 A1 MA 27313A1 MA 28026 A MA28026 A MA 28026A MA 28026 A MA28026 A MA 28026A MA 27313 A1 MA27313 A1 MA 27313A1
- Authority
- MA
- Morocco
- Prior art keywords
- anthelmintic
- ingenious
- formulations
- oral
- animals
- Prior art date
Links
- 230000000507 anthelmentic effect Effects 0.000 title abstract 5
- 235000015927 pasta Nutrition 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 3
- 229940124339 anthelmintic agent Drugs 0.000 abstract 2
- 239000000921 anthelmintic agent Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 abstract 1
- 239000005660 Abamectin Substances 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
- 229960002957 praziquantel Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 abstract 1
- 229960005134 pyrantel Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000002562 thickening agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Cette invention fournit les p??tes homogènes orales pour le traitement, le contrôle et la prévention des infections endo et ectoparasites chez les animaux à sang chaud, comme les chevaux, les animaux domestiques et les oiseaux ainsi que pour le procédé de préparation de ces formulations. Les p??tes anthelminthiques orales ingénieuses comprennent un premier agent anthelminthique comme le praziquantel et/ou pyrantel, et comme un second agent, au moins un corps composé anthélminthique macrolide, comme un avermectine ou milbemycine, dissous dans un dissolvant qui fait dissoudre le premier corps composé anthelminthique et le composé anthelminthique macrolide et un agent épaississant. Les p??tes vétérinaires orales ingénieuses offrent un traitement plus effectif des infections parasitiques chez les animaux non humains puisque les ingrédients actifs ne s'interfèrent pas entre eux, et donc développent la bio disponibilité chez l'animal, en gardant les bénéfices de se distribuer toujours comme une p??te. En outre, les formulations ingénieuses offrent une formulation qui montre une bonne stabilité chimique et physique sur la durée de vie en stock du produit. Ainsi, les formulations vétérinaires orales de l'invention montrent les bénéfices des deux p??tes comme les deux solution et formulation. En outre, l'invention présente offre un procédé de fabrication des formulations ingénieuses ainsi qu'une méthode pour le développement de la bio disponibilité du premier agent anthelminthique et le composé anthélementique macrolide chez l'animal ou l'oiseau à sang chaud. Ces contenus ou autres sont révélés ou sont une forme claire et comprise par la description détaillée suivante.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/177,822 US7001889B2 (en) | 2002-06-21 | 2002-06-21 | Anthelmintic oral homogeneous veterinary pastes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27313A1 true MA27313A1 (fr) | 2005-05-02 |
Family
ID=29734505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28026A MA27313A1 (fr) | 2002-06-21 | 2004-12-30 | Pates veterinaires homogenes orales anthelminthiques. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7001889B2 (fr) |
| EP (1) | EP1534072B1 (fr) |
| JP (1) | JP4342440B2 (fr) |
| AR (1) | AR039722A1 (fr) |
| AT (1) | ATE390123T1 (fr) |
| AU (1) | AU2009200336B2 (fr) |
| BR (1) | BR0312141A (fr) |
| CA (1) | CA2490309C (fr) |
| CY (1) | CY1108533T1 (fr) |
| DE (1) | DE60319996T2 (fr) |
| DK (1) | DK1534072T3 (fr) |
| ES (1) | ES2306879T3 (fr) |
| MA (1) | MA27313A1 (fr) |
| MX (1) | MXPA05000172A (fr) |
| NZ (2) | NZ537407A (fr) |
| PT (1) | PT1534072E (fr) |
| SI (1) | SI1534072T1 (fr) |
| TN (1) | TNSN04258A1 (fr) |
| WO (1) | WO2004000034A2 (fr) |
| ZA (1) | ZA200410250B (fr) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6893652B2 (en) | 2001-08-27 | 2005-05-17 | Wyeth | Endoparasiticidal gel composition |
| US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
| US20060205681A1 (en) * | 2002-06-21 | 2006-09-14 | Maryam Moaddeb | Homogenous paste formulations |
| BRPI0409185B1 (pt) * | 2003-04-04 | 2018-05-15 | Merial, Inc | Formulações veterinárias anti-helmínticas tópicas |
| ATE534900T1 (de) * | 2003-07-09 | 2011-12-15 | Life Technologies Corp | Verfahren zum testen einer protein-protein- wechselwirkung |
| US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
| US7671034B2 (en) * | 2003-12-19 | 2010-03-02 | Merial Limited | Stabilized formulation of ivermectin feed premix with an extended shelf life |
| SI1566173T1 (sl) * | 2004-02-20 | 2006-12-31 | Mattern Udo | Farmacevtska zmes za oralno aplikacijo in postopek njene priprave |
| WO2005094210A2 (fr) * | 2004-03-12 | 2005-10-13 | The Hartz Mountain Corporation | Formulations anthelmintiques a actions multiples |
| ATE555796T1 (de) * | 2004-09-09 | 2012-05-15 | Warburton Technology Ltd | Spurenelemente |
| DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
| US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
| AU2006100657C4 (en) * | 2006-05-15 | 2009-09-10 | Wyeth | Stabilised formulation |
| CA2656617C (fr) | 2006-07-05 | 2014-10-14 | Aventis Agriculture | Composes derives de 1-aryl-5-alkylpyrazole, procedes de fabrication et procedes d'utilisation de ceux-ci |
| NZ550279A (en) * | 2006-09-29 | 2008-01-31 | Bomac Research Ltd | Medicament |
| ES2597083T3 (es) | 2007-05-15 | 2017-01-13 | Merial, Inc. | Compuestos de ariloazol-2-il cianoetilamino, procedimiento de fabricación y procedimiento de utilización de los mismos |
| EP2214656B1 (fr) | 2007-10-26 | 2018-12-05 | Avivagen Inc. | Compositions et procédés pour améliorer la réponse immunitaire |
| US20100286154A1 (en) * | 2007-11-15 | 2010-11-11 | Susanne Christine Wieland-Berghausen | Antihelmintic paste |
| NZ590141A (en) * | 2008-06-24 | 2012-05-25 | Merial Ltd | Anthelminthic formulations including castor oil and another vegetable oil |
| WO2010022263A2 (fr) * | 2008-08-20 | 2010-02-25 | Futurefuel Chemical Company | Procédé de préparation de glycérol formal |
| MX2009001235A (es) * | 2008-09-19 | 2010-04-29 | Agrovet Market S A | Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina. |
| MY153715A (en) | 2008-11-14 | 2015-03-13 | Merial Ltd | Enantiomerically enriched aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
| ES2781828T3 (es) | 2008-11-19 | 2020-09-08 | Boehringer Ingelheim Animal Health Usa Inc | Composiciones que comprenden un aril pirazol y/o una formamidina, procedimientos y usos de las mismas |
| JP5595412B2 (ja) | 2008-12-04 | 2014-09-24 | メリアル リミテッド | 二量体アベルメクチン及びミルベマイシン誘導体 |
| AU2010242502B2 (en) | 2009-04-30 | 2016-11-10 | Avivagen Inc. | Methods and compositions for improving the health of animals |
| TW201041508A (en) * | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity |
| BR112012002164B1 (pt) | 2009-07-30 | 2021-04-20 | Merial, Inc | compostos inseticidas de 4-amino-tieno[2,3-d]-pirimidina e métodos para seu uso |
| ES2546100T3 (es) | 2009-12-04 | 2015-09-18 | Merial, Inc. | Compuestos pesticidas bis-organosulfurados |
| NZ600845A (en) | 2009-12-17 | 2014-08-29 | Merial Ltd | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
| EP3078664B1 (fr) | 2009-12-17 | 2019-02-20 | Merial Inc. | Compositions antiparasitaires comprenant dihydroazoles |
| UA108641C2 (uk) | 2010-04-02 | 2015-05-25 | Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування | |
| NZ610547A (en) | 2010-11-16 | 2015-07-31 | Merial Ltd | Novel monensin derivatives for the treatment and prevention of protozoal infections |
| ES2618813T3 (es) | 2011-06-27 | 2017-06-22 | Merial, Inc. | Compuestos y composiciones de éter amido-piridílico y uso contra los parásitos |
| WO2013003168A1 (fr) | 2011-06-27 | 2013-01-03 | Merial Limited | Dérivés insectifuges inédits de coumarine, leur synthèse et leurs procédés d'utilisation |
| CN104023720B (zh) | 2011-11-17 | 2016-10-26 | 梅里亚有限公司 | 包含芳基吡唑和取代咪唑的组合物，其方法和用途 |
| EP2594258B1 (fr) | 2011-11-18 | 2020-03-18 | Veterinärmedizinische Universität Wien | Gel oral comprenant du praziquantel |
| EP3351546B9 (fr) | 2011-12-02 | 2024-07-10 | Boehringer Ingelheim Vetmedica GmbH | Formulations de moxidectine injectables à action prolongée |
| CN104168886A (zh) * | 2012-03-13 | 2014-11-26 | 拜耳新西兰有限公司 | 长效组合物 |
| PL2922845T3 (pl) | 2012-11-20 | 2018-11-30 | Merial, Inc. | Związki przeciwrobacze oraz ich kompozycje i sposób stosowania |
| WO2015064680A1 (fr) * | 2013-10-30 | 2015-05-07 | 大蔵製薬株式会社 | Composition pharmaceutique sous forme de gelée facile à prendre |
| DK3063144T3 (da) | 2013-11-01 | 2021-10-25 | Boehringer Ingelheim Animal Health Usa Inc | Antiparasitære og pesticid-isoxazolinforbindelser |
| CA2949511A1 (fr) | 2014-05-19 | 2015-11-26 | Merial, Inc. | Composes anthelmintiques |
| MX384433B (es) * | 2014-10-01 | 2025-03-14 | Boehringer Ingelheim Animal Health Usa Inc | Prueba de disolución de ingredientes activos farmacéuticos hidrofóbicos tal como avermectinas con o sin pirantel. |
| CN107835818B (zh) | 2015-05-20 | 2022-04-29 | 勃林格殷格翰动物保健美国公司 | 驱虫缩酚酸肽化合物 |
| UY40429A (es) | 2016-02-24 | 2023-10-13 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
| US10137111B2 (en) | 2016-08-11 | 2018-11-27 | Adamis Pharmaceuticals Corporation | Drug compositions comprising an anti-parasitic and proton pump inhibitor |
| WO2018039508A1 (fr) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Procédé de réduction d'effets indésirables dans des traitements antiparasitaires |
| AU2017344097A1 (en) | 2016-10-14 | 2019-05-02 | Boehringer Ingelheim Animal Health USA Inc. | Pesticidal and parasiticidal vinyl isoxazoline compounds |
| EP3541789A1 (fr) | 2016-11-16 | 2019-09-25 | Boehringer Ingelheim Animal Health USA Inc. | Composés depsipeptidiques anthelminthiques |
| MX2020001724A (es) | 2017-08-14 | 2020-07-29 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas. |
| RU2681214C1 (ru) * | 2017-10-12 | 2019-03-05 | Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук | Способ получения средства для лечения однокопытных животных при паразитозах |
| WO2019113493A1 (fr) | 2017-12-08 | 2019-06-13 | Adamis Pharmaceuticals Corporation | Compositions de médicaments |
| US11583545B2 (en) | 2018-02-08 | 2023-02-21 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof |
| US12269822B2 (en) | 2018-07-09 | 2025-04-08 | Boehringer Ingelheim Animal Health USA Inc. | Anthelminthic heterocyclic compounds |
| WO2020112374A1 (fr) | 2018-11-20 | 2020-06-04 | Boehringer Ingelheim Animal Health USA Inc. | Composé indazolylcyanoéthylamino, compositions associées, procédé de fabrication et procédés d'utilisation de celui-ci |
| MX2021011302A (es) | 2019-03-19 | 2022-01-19 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos. |
| KR20230028268A (ko) | 2020-05-29 | 2023-02-28 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 구충성 헤테로시클릭 화합물 |
| EP4208157A1 (fr) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Formulations palatables |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3502661A (en) * | 1967-02-14 | 1970-03-24 | Pfizer & Co C | Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl) pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines |
| US4001441A (en) * | 1970-12-21 | 1977-01-04 | The Procter & Gamble Company | Meat analog |
| US3950360A (en) * | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
| US4196291A (en) * | 1973-12-17 | 1980-04-01 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof |
| IN142490B (fr) * | 1974-05-15 | 1977-07-16 | Bayer Ag | |
| US4032655A (en) * | 1974-05-15 | 1977-06-28 | Bayer Aktiengesellschaft | Phenylguanidines useful as anthelmintic agents |
| SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US5089490A (en) * | 1977-04-02 | 1992-02-18 | Hoechst Aktiengesellschaft | Cephem derivatives |
| US4197307A (en) * | 1977-04-12 | 1980-04-08 | Ciba-Geigy Corporation | 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents |
| US4199569A (en) * | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
| NZ188459A (en) | 1977-10-03 | 1982-09-07 | Merck & Co Inc | Derivatives of c-076 compounds and pesticidal compositions |
| PH15982A (en) | 1977-10-03 | 1983-05-18 | Merck & Co Inc | Selective hydrogenation producta of c-076 compounds and derivatives thereof |
| US4200581A (en) * | 1978-08-04 | 1980-04-29 | Merck & Co., Inc. | Alkyl derivatives of C-076 compounds |
| EP0021758B1 (fr) | 1979-06-27 | 1984-04-04 | Beecham Group Plc | Préparations vétérinaires pour ruminants |
| JPS57139012A (en) * | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
| US4427663A (en) * | 1982-03-16 | 1984-01-24 | Merck & Co., Inc. | 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof |
| US4633372A (en) | 1985-08-26 | 1986-12-30 | The Standard Oil Company | Polyoxometalate-modified carbon electrodes and uses therefor in capacitors |
| EP0237482A1 (fr) * | 1986-03-06 | 1987-09-16 | Ciba-Geigy Ag | Dérivés de la C(29)-carbonyloxy-milbémycine pour la lutte contre les parasites d'espèces végétales ou animales |
| EP0342710B1 (fr) * | 1986-03-25 | 1993-05-19 | Sankyo Company Limited | Dérivés du type macrolide, leur préparation et leur utilisation |
| ATE75745T1 (de) * | 1986-07-02 | 1992-05-15 | Ciba Geigy Ag | Pestizide. |
| US4855317A (en) * | 1987-03-06 | 1989-08-08 | Ciba-Geigy Corporation | Insecticides and parasiticides |
| US4871719A (en) * | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
| US4874749A (en) * | 1987-07-31 | 1989-10-17 | Merck & Co., Inc. | 4"-Deoxy-4-N-methylamino avermectin Bla/Blb |
| DE3888936T2 (de) * | 1987-11-03 | 1994-07-21 | Beecham Group Plc | Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung. |
| NZ232422A (en) * | 1989-02-16 | 1992-11-25 | Merck & Co Inc | 13-ketal milbemycin derivatives and parasiticides |
| JP2893901B2 (ja) | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
| JP3182229B2 (ja) | 1992-09-17 | 2001-07-03 | 大日本製薬株式会社 | 動物用懸濁型ペースト剤 |
| US5345377A (en) | 1992-10-30 | 1994-09-06 | Electric Power Research Institute, Inc. | Harmonic controller for an active power line conditioner |
| IL108366A (en) * | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
| AUPM969994A0 (en) * | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
| DE19520275A1 (de) | 1995-06-02 | 1996-12-05 | Bayer Ag | Endoparasitizide Mittel |
| AU707949C (en) * | 1996-07-30 | 2006-01-19 | Merial, Inc. | Anthelmintic formulations |
| IL126741A0 (en) | 1998-10-25 | 1999-08-17 | Yam Daniel | Solidification of fluid oils and their use |
| NZ336832A (en) | 1999-07-21 | 2000-10-27 | Ancare New Zealand Ltd | Anthelmintic formulation comprising praziquantel, a macrolide, a preservative, buffer salts, defoaming agent, dispersing agent and water |
| US6787342B2 (en) | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
| US6340672B1 (en) * | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
| US6207179B1 (en) * | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
| US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
-
2002
- 2002-06-21 US US10/177,822 patent/US7001889B2/en not_active Expired - Lifetime
-
2003
- 2003-06-13 MX MXPA05000172A patent/MXPA05000172A/es active IP Right Grant
- 2003-06-13 JP JP2004515836A patent/JP4342440B2/ja not_active Expired - Lifetime
- 2003-06-13 NZ NZ537407A patent/NZ537407A/en not_active IP Right Cessation
- 2003-06-13 DE DE60319996T patent/DE60319996T2/de not_active Expired - Lifetime
- 2003-06-13 SI SI200331229T patent/SI1534072T1/sl unknown
- 2003-06-13 NZ NZ555185A patent/NZ555185A/en not_active IP Right Cessation
- 2003-06-13 EP EP03737140A patent/EP1534072B1/fr not_active Expired - Lifetime
- 2003-06-13 AT AT03737140T patent/ATE390123T1/de active
- 2003-06-13 WO PCT/US2003/019025 patent/WO2004000034A2/fr not_active Ceased
- 2003-06-13 ES ES03737140T patent/ES2306879T3/es not_active Expired - Lifetime
- 2003-06-13 DK DK03737140T patent/DK1534072T3/da active
- 2003-06-13 PT PT03737140T patent/PT1534072E/pt unknown
- 2003-06-13 CA CA2490309A patent/CA2490309C/fr not_active Expired - Lifetime
- 2003-06-13 BR BR0312141-0A patent/BR0312141A/pt not_active Application Discontinuation
- 2003-06-20 AR ARP030102207A patent/AR039722A1/es not_active Application Discontinuation
-
2004
- 2004-12-20 ZA ZA2004/10250A patent/ZA200410250B/en unknown
- 2004-12-21 TN TNP2004000258A patent/TNSN04258A1/en unknown
- 2004-12-30 MA MA28026A patent/MA27313A1/fr unknown
-
2005
- 2005-04-15 US US11/107,048 patent/US7563773B2/en not_active Expired - Lifetime
-
2008
- 2008-06-24 CY CY20081100661T patent/CY1108533T1/el unknown
-
2009
- 2009-01-30 AU AU2009200336A patent/AU2009200336B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATE390123T1 (de) | 2008-04-15 |
| PT1534072E (pt) | 2008-06-03 |
| JP2005533806A (ja) | 2005-11-10 |
| CA2490309A1 (fr) | 2003-12-31 |
| AU2003238245A1 (en) | 2004-01-06 |
| JP4342440B2 (ja) | 2009-10-14 |
| TNSN04258A1 (en) | 2007-03-12 |
| US7001889B2 (en) | 2006-02-21 |
| MXPA05000172A (es) | 2005-06-03 |
| NZ555185A (en) | 2009-04-30 |
| DK1534072T3 (da) | 2008-07-14 |
| CA2490309C (fr) | 2011-09-27 |
| WO2004000034A3 (fr) | 2004-02-26 |
| NZ537407A (en) | 2007-07-27 |
| WO2004000034A2 (fr) | 2003-12-31 |
| US7563773B2 (en) | 2009-07-21 |
| EP1534072A2 (fr) | 2005-06-01 |
| ES2306879T3 (es) | 2008-11-16 |
| EP1534072A4 (fr) | 2005-10-26 |
| US20030236203A1 (en) | 2003-12-25 |
| EP1534072B1 (fr) | 2008-03-26 |
| DE60319996T2 (de) | 2009-05-20 |
| AU2009200336A1 (en) | 2009-02-19 |
| DE60319996D1 (de) | 2008-05-08 |
| AR039722A1 (es) | 2005-03-09 |
| US20050176657A1 (en) | 2005-08-11 |
| BR0312141A (pt) | 2005-06-28 |
| AU2009200336B2 (en) | 2011-09-15 |
| SI1534072T1 (sl) | 2008-10-31 |
| CY1108533T1 (el) | 2014-04-09 |
| ZA200410250B (en) | 2005-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27313A1 (fr) | Pates veterinaires homogenes orales anthelminthiques. | |
| MA34655B1 (fr) | Dérivés de 2,3- dihydroimidazo[1,2-c]quinazoléine substitués par un aminoalcool utiles pour traiter des troubles hyperprolifératifs et des maladies associées à l'angiogenèse | |
| BR9911596A (pt) | Nucleosìdeos tendo porção açúcar bicìclico | |
| MA31283B1 (fr) | Produits dérivés de 2,3-dihydroimidazo[1,2-c]quinazoline substitués, utiles pour le traitement de troubles hyperlifératifs et de maladies associées à une angiogénèse | |
| HRP20060251A2 (en) | Substituted oxasolidinones and their use | |
| MA26946A1 (fr) | Derives de pyrazole nouveaux et leur utilisation comme inhibiteurs de proteine-kinases. | |
| WO2003105800A3 (fr) | Forme galenique, se presentant sous forme de film adherant a la muqueuse, pour l'administration de principes actifs du cannabis | |
| TNSN00065A1 (fr) | Derives nouveaux de pyrimidine inhibiteurs de sorbitol- deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant. | |
| WO2004071447A3 (fr) | Utilisation de derives d'azoles substitues en tant qu'agents therapeutiques | |
| MA27428A1 (fr) | Derives de pyrimidine et leur utilisation en tant que modulateurs cb2 | |
| MA27867A1 (fr) | Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif. | |
| CN101257897A (zh) | 用于治疗或预防肥胖、胰岛素抵抗障碍和线粒体相关障碍的方法和相关组合物 | |
| EA200400735A1 (ru) | 3-β-D-РИБОФУРАНОЗИЛТИАЗОЛО[4,5-d]ПИРИМИДИННУКЛЕОЗИДЫ И ИХ ПРИМЕНЕНИЯ | |
| ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
| ATE237587T1 (de) | 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten | |
| KR927003615A (ko) | 항바이러스 피리미딘 뉴클레오티드 | |
| MA27087A1 (fr) | Compositions pharmaceutiques comprenant le glibenclamide et la metformine destinees au traitement du diabete sucre de type ii | |
| WO2006050389A3 (fr) | Composes pyridazine, compositions et procedes associes | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| MA28038A1 (fr) | Thienopyrazoles | |
| SE9804212D0 (sv) | Compounds | |
| BR9916190A (pt) | Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas | |
| MA30292B1 (fr) | Amines primaires comme inhibiteurs de la renine | |
| CY1108145T1 (el) | Σταθερες συνθεσεις για παρεντερικη χορηγηση | |
| TNSN06370A1 (fr) | Derives de pyrimidine pour le traitement d'une croissance cellulaire anormale |